RenovoRx Reports Initial Revenues from RenovoCath® and Phase III TIGeR-PaC Trial Update RenovoRx, Inc. (Nasdaq: RNXT), a life sciences company focused on developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel FDA-cleared drug delivery device, has announced its financial…
Siemens Healthineers’ Antithrombin Blood Test FDA Cleared as Companion Diagnostic for Sanofi’s Qfitlia Hemophilia Therapy Siemens Healthineers announced that its Innovance Antithrombin assay has received FDA clearance for a new indication, allowing it to be used as a companion diagnostic…
Epitel’s REMI EEG System Gets Expanded FDA Clearance for Patients Aged One and Up Epitel, a leader in AI-driven brain health solutions, has announced that the U.S. Food and Drug Administration (FDA) has granted expanded 510(k) clearance for the REMI™…
Corcept’s Phase 3 ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer Meets Primary Endpoint Corcept Therapeutics Incorporated (NASDAQ: CORT), a company focused on developing treatments for serious endocrinologic, oncologic, metabolic, and neurologic disorders by modulating cortisol, announced that its pivotal…
ENDRA Life Sciences Announces Strategy for Early Detection and Management of Metabolic Diseases with GLP-1 Therapies ENDRA Life Sciences Inc. (NASDAQ: NDRA), a leader in Thermo-Acoustic Enhanced UltraSound (TAEUS®) technology, recently announced a new strategic direction to develop and deploy…
ABEC Launches Breakthrough Single-Use Bioreactor Technology for Cell Therapy ABEC, a global leader in engineered solutions and services for biotech manufacturing, has unveiled its Advanced Therapy Bioreactor (ATB™), a groundbreaking platform designed to revolutionize cell expansion for Advanced Therapy Medicinal…
Cell Therapy for Male Urethral Stricture: BEES-HAUS Trial at Edogawa Hospital, Japan Urethral stricture, a condition that affects men across all age groups but becomes more prevalent after the age of 55, remains a challenging issue despite the availability of…
Exact Sciences Launches Cologuard Plus™ Test for Colorectal Cancer Screening Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer screening and diagnostic tests, has announced the launch of Cologuard Plus™, a groundbreaking noninvasive colorectal cancer (CRC) screening test. The Cologuard…
Enigma Biomedical Partners to Use 4R PET Imaging Biomarkers in CTE Research Enigma Biomedical USA, Inc. (EB USA) has announced an exciting new collaboration with the Boston University Chronic Traumatic Encephalopathy (CTE) Center and the Concussion Legacy Foundation. This partnership…
Sphere Bio Launches Cyto-Cellect IgG Kappa and Viability Assay Kit for Single-Cell Selection Sphere Bio, a leader in picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, has unveiled the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit. This is…
Convatec Partners with Leading Wound, Ostomy, and Continence Nursing Organization Convatec, a global leader in medical products and technologies focused on managing chronic conditions, has announced an exciting new collaboration with the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the…
SBC Medical Group Reports Q4 and Full Year 2024 Financial Results SBC Medical Group Holdings Incorporated (NASDAQ: SBC), a global leader in aesthetic practice management services and products, has announced its financial results for the fourth quarter and full year…